Abstract
The gut microbiome can play important role in maintaining homeostasis in the human body. An imbalance in the gut microbiome can lead to pro-inflammatory immune responses and the initiation of disease processes, including cancer. The research results prove some strains of probiotics by modulating intestinal microbiota and immune response can be used for cancer prevention or/and as adjuvant treatment during anticancer chemotherapy. This review presents the latest advances in research into the effectiveness of probiotics in the prevention and treatment support of cancer. The described issues concern to the anticancer activity of probiotic microorganisms and their metabolites. In addition, we described the potential mechanisms of probiotic chemoprevention and the advisability of using probiotics.
Reference142 articles.
1. Intestinal flora and the pathophysiology of depression and anxiety disorders—Current state of the art and future perspectives;Liśkiewicz;Psychiatry,2018
2. The mind-body-microbial continuum. Dialogues;Gonzalez;Clin. Neurosci.,2011
3. Molecular Genetics of Bacteria;Snyder,1997
4. Gut microbiota and short-chain fatty acids (SCFAs) profiles of normal and overweight school children in Selangor after probiotics administration
5. Anxiety, Depression, and the Microbiome: A Role for Gut Peptides
Cited by
95 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献